Advertisement

Archives of Orthopaedic and Trauma Surgery

, Volume 131, Issue 3, pp 389–392 | Cite as

Are venotonic drugs effective for decreasing acute posttraumatic oedema following ankle sprain? A prospective randomized clinical trial

  • Elias FotiadisEmail author
  • Eustathios Kenanidis
  • Efthimios Samoladas
  • Anastasios Chytas
  • Christos Lyrtzis
  • Miltiadis Koimtzis
  • Byron Chalidis
Orthopaedic Outcome Assessment

Abstract

Objective

Lower leg oedema after trauma may cause various degrees of pain, disability and delay in patient recovery. In this prospective randomized study, we hypothesized that venotonic drugs had no effect in clinical outcome of patients with ankle sprain.

Patients and methods

Eighty-one patients with type II and III ankle sprain were screened and randomly assigned for receiving standard conservative treatment alone (control group, 39 patients) or with oral intake of a venotonic drug (micronized purified flavonoid fraction, Daflon 1,000 mg × 3) for 20 days (study group, 42 patients). Measurement of the circumference of ankle region in two different locations and assessment of pain intensity with the Visual Analogue Score were performed at the time of patients’ admission and during the 7th and 20th posttraumatic day.

Results

Patients demographics were comparable in both groups. There were no significant differences between the two groups regarding the values of perimeter of ankle joint or pain intensity at all the examined time points.

Conclusions

Venotonic drugs seem not to decrease the posttraumatic oedema or pain in patients who suffer from moderate or severe ankle sprain.

Keywords

Ankle sprain Venotonic drugs Posttraumatic oedema Pain Ankle circumference 

References

  1. 1.
    Wexler RK (1998) The injured ankle. Am Fam Physician 57:474–480PubMedGoogle Scholar
  2. 2.
    Ivins D (2006) Acute ankle sprain: an update. Am Fam Phys 74(10): 1714–1720Google Scholar
  3. 3.
    Boyce SH, Quigley MA, Campbell S (2005) Management of ankle sprains: a randomized controlled trial of the treatment of inversion injuries using an elastic support bandage or an Aircast ankle brace. Br J Sports Med 39:91–96CrossRefPubMedGoogle Scholar
  4. 4.
    Safran MR, Zachazewski JE, Benedetti RS et al (1999) Lateral ankle sprains: a comprehensive review part2: treatment and rehabilitation with an emphasis on the athlete. Med Sci Sports Exerc 31(7 suppl):S438–S447PubMedGoogle Scholar
  5. 5.
    Slatyer MA, Hensley MJ, Lopert R (1997) A randomized controlled trial of piroxicam in the management of acute ankle sprain in Australian Regular Army recruits, The Kapooka Ankle Sprain Study. Am J Sports Med 25:544–553CrossRefPubMedGoogle Scholar
  6. 6.
    Wilkerson GB, Horn-Kingery HM (1993) Treatment of the inversion ankle sprain: comparison of different modes of compression and cryotherapy. J Orthop Sports Phys Ther 17:240–246PubMedGoogle Scholar
  7. 7.
    Calandre EP, Ruiz-Morales M, Lopez-Gollonet JM et al (1991) Efficacy of oral streptokinase-streptodornase in the treatment of ankle sprains. Clin Orthop Relat Res 263:210–214PubMedGoogle Scholar
  8. 8.
    Buckshee K, Takkar D, Aggarwal N (1997) Micronized flavonoid therapy in internal hemorrhoids of pregnancy. Int J Gynaecol Obstet 57:145–151CrossRefPubMedGoogle Scholar
  9. 9.
    Meyer OC (1994) Safety and security of Daflon 500 mg in venous insufficiency and in hemorrhoidal disease. Angiology 45:579–584PubMedGoogle Scholar
  10. 10.
    Galley P, Thiollet M (1993) A double-blind, placebo-controlled trial of a new veno-active flavonoid fraction (S 5682) in the treatment of symptomatic capillary fragility. Int Angiol 12(1):69–72PubMedGoogle Scholar
  11. 11.
    Ibegbuna V, Nicolaides AN, Sowade O et al (1997) Venous elasticity after treatment with Daflon 500 mg. Angiology 48(1):45–49CrossRefPubMedGoogle Scholar
  12. 12.
    Shoab SS, Porter J, Scurr JH et al (1999) Endothelial activation response to oral micronised flavonoid therapy in patients with chronic venous disease—a prospective study. Eur J Vasc Endovasc Surg 17(4):313–318CrossRefPubMedGoogle Scholar
  13. 13.
    Szczesny G, Veihelmann A, Nolte D et al (2001) Changes in the local blood and lymph microcirculation in response to direct mechanical trauma applied to leg: in vivo study in an animal model. J Trauma 51(3):508–517CrossRefPubMedGoogle Scholar
  14. 14.
    Dominguez C, Brautigam I, Gonzalez F et al (1992) Therapeutic effects of hidrosmin on chronic venus insufficiency of the lower limbs. Curr Med Res Opin 12(10):623–630PubMedGoogle Scholar
  15. 15.
    Kiesewetter H, Koscielny J, Kalus U et al (2000) Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I–II). A randomised, double-blind, placebo-controlled trial. Arzneimittelforschung 50(2):109–117PubMedGoogle Scholar
  16. 16.
    Szczesny G, Olszewski WL (2003) The pathomechanism of posttraumatic edema of the lower limbs: II—changes in the lymphatic system. J Trauma 55(2):350–354CrossRefPubMedGoogle Scholar
  17. 17.
    Lonchampt M, Guardiola B, Sicot N et al (1989) Protective effect of a purified flavonoid fraction against reactive oxygen radicals. In vivo and in vitro study. Arzneimittelforschung 39(8):882–885PubMedGoogle Scholar
  18. 18.
    Damon M, Flandre O, Michel F et al (1987) Effect of chronic treatment with a purified flavonoid fraction on inflammatory granuloma in the rat. Study of prostaglandin E2 and F2 alpha and thromboxane B2 release and histological changes. Arzneimittelforschung 37(10):1149–1153PubMedGoogle Scholar
  19. 19.
    Kerkhoffs GM, Rowe BH, Assendelft WJ et al (2001) Immobilization for acute ankle sprain. A systematic review. Arch Orthop Trauma Surg 121(8):462–471CrossRefPubMedGoogle Scholar
  20. 20.
    Filis KA, Georgopoulos SE, Papas SC et al (1999) Therapeutic efficacy of flavonoids in oedema following reperfusion on acutely ischaemic legs. Int Angiol 18(4):327–330PubMedGoogle Scholar
  21. 21.
    Tsouderos Y (1989) Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg. Int Angiol 8(4 Suppl):53–59PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Elias Fotiadis
    • 1
    Email author
  • Eustathios Kenanidis
    • 1
  • Efthimios Samoladas
    • 2
  • Anastasios Chytas
    • 1
  • Christos Lyrtzis
    • 1
  • Miltiadis Koimtzis
    • 1
  • Byron Chalidis
    • 2
  1. 1.Orthopaedic DepartmentGeneral Hospital of VeriaVeriaGreece
  2. 2.Aristotle University of Thessaloniki, Medical SchoolThessalonikiGreece

Personalised recommendations